Heron Therapeutics (HRTX) Reports Q4 Loss, Lags Revenue Estimates
28/2 23:45
Heron Therapeutics (HRTX) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.68 per share a year ago. These figures are adjusted for non-recurring items....